InnoCan Pharma Corporation
INNO
Rangering i aksjer
#33937
InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to... InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems that integrate cannabidiol (CBD) with other pharmaceutical compounds. Its operations and development efforts span across the United States, Poland, France, and various international markets. The company actively pursues research and development into treatments for conditions such as COVID-19, leveraging CBD delivered via exosomes and liposomes. InnoCan's product line features a range of CBD-infused topical items, including eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Beyond R&D, the corporation is also involved in the marketing and distribution of its proprietary CBD-enhanced pharmaceutical and cosmetic offerings. Established in 2018, InnoCan Pharma Corporation maintains its principal office in Calgary, Canada.
Aksjekurs
$1.35
Sist synkronisert: 2026-10-19
Markedsverdi
$6.08M
Endring (1 dag)
-3.08%
Endring (1 år)
-89.20%
Land
CA
Handel InnoCan Pharma Corporation (INNO)
Kategori
Healthcare
Aksjeprishistorikk for InnoCan Pharma Corporation (INNO)
Høyeste sluttskurs: $1.37 den 2026-10-01
Laveste sluttskurs: $11.93 den 2020-11-01
Laveste sluttskurs: $11.93 den 2020-11-01
Aksjeprishistorikk for InnoCan Pharma Corporation fra 2020 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2026 (TTM) | -38.79% |
| 2025 | -29.02% |
| 2024 | -47.91% |
| 2023 | 42.26% |
| 2022 | -67.12% |
| 2021 | 201.26% |
| 2020 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 20.52% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $212.49 | 24.09% |
CH
|
|
| $18.43 | -4.05% |
IN
|
